Francesco Draetta

Francesco Draetta is currently the Managing Director at Omega Funds and has held various leadership roles, including Partner and Senior Associate at the same firm. They serve as a Board Director for multiple organizations such as NRG Therapeutics and CHORD Therapeutics, and are a Board Observer at several others, including Marea Therapeutics and ARTBIO. Francesco's career began with positions as an Analyst at firms like Brookside Mezzanine Partners and Merrill Lynch, and they have extensive experience in the biotech and medical sectors. They are pursuing a Bachelor of Business Administration at the University of Massachusetts at Amherst, alongside studies at the Startup Institute and American School of Milan.